Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
2(40%)

Phase Distribution

Ph phase_3
2
40%
Ph phase_1
3
60%

Phase Distribution

3

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 3Large-scale testing
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(3)
Terminated(2)

Detailed Status

Completed3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
60.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (60.0%)
Phase 32 (40.0%)

Trials by Status

terminated240%
completed360%

Recent Activity

0 active trials
Showing 5 of 5
terminatedphase_3

Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)

NCT02313909
terminatedphase_3

Efficacy of a Single Dose of Aspirin vs. Acetaminophen in Tension Type Headache

NCT01552798
completedphase_1

Bioequivalence of Single Dose Fast Release Aspirin (1000 mg) Tablet Versus Single Dose of Two 500 mg Fast Release Aspirin Tablets

NCT03056703
completedphase_1

Pharmacokinetic Study Comparing Aspirin and Effervescent Aspirin

NCT01081353
completedphase_1

Pharmacokinetic Study Comparing Aspirin and Aspirin Granules

NCT01072604

Clinical Trials (5)

Showing 5 of 5 trials
NCT02313909Phase 3

Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)

Terminated
NCT01552798Phase 3

Efficacy of a Single Dose of Aspirin vs. Acetaminophen in Tension Type Headache

Terminated
NCT03056703Phase 1

Bioequivalence of Single Dose Fast Release Aspirin (1000 mg) Tablet Versus Single Dose of Two 500 mg Fast Release Aspirin Tablets

Completed
NCT01081353Phase 1

Pharmacokinetic Study Comparing Aspirin and Effervescent Aspirin

Completed
NCT01072604Phase 1

Pharmacokinetic Study Comparing Aspirin and Aspirin Granules

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5